Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2024-08-19 00:00:00 ET · period of report 2024-08-16 · accession 0001493152-24-033205 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-19 | 2024-08-16 | IMMX | Ng Carey | Dir | P - Purchase | $1.86 | +10.0K | 20.0K | +100% | +$18.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-16 | P | A | 10,000 | $1.86 | 20,000 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $1.84 to $1.915, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |